> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CDER Revises Policy on Posting Approval Info
- URL: https://www.fdaweb.com/cder-revises-policy-on-posting-approval-info/
- Published: 2017-07-17T12:00:00.000Z
- Updated: 2026-09-14T22:34:31.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5139147

FDA has revised an internal policy on “[Communicating Drug Approval Information](https://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ManualofPoliciesProcedures/UCM078818.pdf?ref=fdaweb.com)” that demands quicker online posting, from three days to two days, for the approved labeling for recently approved drugs. The policy also lays out the posting schedule for approved risk evaluation and mitigation strategy documents, a summary review and the action packages for approved applications.